Kidney failure - Nursing Case Study
Pathophysiology
• Primary mechanism: Reduced glomerular filtration rate (GFR) - In kidney failure, the nephrons lose their filtering capacity, leading to accumulation of waste products and electrolytes in the blood, which disrupts homeostasis.
• Secondary mechanism: Tubular damage - Damage to the renal tubules impairs reabsorption and secretion processes, resulting in imbalances in fluid, electrolytes, and acid-base status, further exacerbating kidney dysfunction.
• Key complication: Uremia - As waste products build up, uremia can develop, manifesting in symptoms such as nausea, fatigue, and neurological disturbances, necessitating immediate medical intervention to prevent systemic toxicity.
Patient Profile
Demographics:
56-year-old male, retired factory worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Furosemide
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased fatigue and swelling in legs
• Key symptoms: Reduced urine output, shortness of breath, nausea
• Vital signs: Blood pressure 162/98 mmHg, heart rate 88 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air
Section 1
During the initial assessment, the nurse noted the patient's significant bilateral pitting edema in the lower extremities, consistent with fluid retention. Additionally, lung auscultation revealed bilateral crackles, suggesting pulmonary congestion, which could be attributed to fluid overload secondary to renal insufficiency. The patient's jugular venous pressure was elevated, indicating increased central venous pressure. These findings, combined with the shortness of breath and peripheral edema, pointed towards the development of volume overload, a common complication in kidney failure due to reduced excretion capabilities.
To further evaluate the patient's kidney function and pinpoint possible complications, a comprehensive metabolic panel was ordered. The lab results indicated elevated blood urea nitrogen (BUN) at 45 mg/dL and serum creatinine at 3.8 mg/dL, confirming the progression of kidney dysfunction. Additionally, electrolyte imbalances were evident, with hyperkalemia (potassium at 5.8 mEq/L) and metabolic acidosis (bicarbonate at 18 mEq/L), both of which require immediate attention to prevent cardiac and systemic complications. The urinalysis showed proteinuria and a high specific gravity, supporting the diagnosis of deteriorating renal function.
These findings compelled the healthcare team to consider adjustments in the treatment plan. Given the hyperkalemia and fluid overload, initiating hemodialysis was contemplated to manage the waste product accumulation and correct electrolyte imbalances. The patient's antihypertensive regimen was reevaluated, considering the elevated blood pressure, which could further compromise renal perfusion. Engaging in interdisciplinary collaboration, the team prepared to educate the patient on dietary modifications to manage potassium and fluid intake, emphasizing the need for close monitoring and follow-up care to prevent further complications.
Section 2
As the healthcare team moved forward with the treatment plan, the patient was scheduled for urgent hemodialysis to address the hyperkalemia and fluid overload. The dialysis session was initiated without complications, and initial post-dialysis evaluation showed a reduction in serum potassium to 4.8 mEq/L, suggesting an effective clearance of excess potassium. The patient also reported a slight improvement in breathing, with reduced crackles upon lung auscultation, indicating alleviation of pulmonary congestion. Despite these improvements, the patient's blood pressure remained elevated at 160/95 mmHg, necessitating further adjustments to the antihypertensive regimen to protect renal function and prevent cardiovascular strain.
In the following days, the patient began to exhibit new symptoms of lethargy and confusion, which prompted additional neurological assessment. The nurse noted a decreased level of consciousness and difficulty in maintaining attention during conversations. These changes raised concerns about possible uremic encephalopathy, a condition associated with the accumulation of urea and other toxins in the blood due to inadequate renal clearance. A repeat comprehensive metabolic panel was ordered and revealed persistent metabolic acidosis, with bicarbonate levels remaining low at 17 mEq/L despite dialysis. This suggested ongoing acid-base imbalance, which could contribute to the neurological symptoms.
To address these new complications, the healthcare team considered increasing the frequency of dialysis sessions to enhance toxin removal and stabilize electrolyte levels. Additionally, a nephrology consult was requested to explore potential adjustments in the dialysis prescription, such as altering the dialysate composition to better correct the acid-base disturbances. The interdisciplinary team also planned to closely monitor the patient’s neurological status and assess for any further cognitive changes. Through these targeted interventions, the goal was to mitigate the patient's symptoms, improve their overall condition, and prevent further deterioration of renal and systemic function.
Section 3
As the healthcare team continued to manage the patient's condition, they closely monitored the patient's neurological status and overall response to the increased frequency of dialysis sessions. After the third consecutive day of dialysis, the patient exhibited some improvement in alertness, with periods of clearer speech and better attention during conversations. The healthcare team noted a slight but important improvement in the patient's ability to follow commands and engage with the medical staff, suggesting a positive initial response to the enhanced toxin clearance.
Despite these encouraging signs, the latest set of laboratory results revealed persistent challenges. The serum bicarbonate level had marginally improved to 18 mEq/L, yet the metabolic acidosis remained unresolved. Additionally, a new finding emerged: the patient's serum phosphorus level had increased to 6.5 mg/dL, above the normal range, raising concerns about the risk of further complications such as pruritus or calcification in soft tissues. The elevated phosphorus levels prompted the team to incorporate phosphate binders into the treatment regimen to prevent further elevation and to protect against additional cardiovascular and skeletal complications.
The patient’s blood pressure, however, remained a point of concern, stubbornly elevated at 155/92 mmHg despite adjustments in antihypertensive medications. This necessitated a re-evaluation of the current medication regimen to provide adequate blood pressure control while safeguarding renal function. The nephrology team recommended a combination of medications including a calcium channel blocker and an angiotensin-converting enzyme inhibitor to address the multi-faceted nature of the patient's hypertension. The team anticipated that with continued dialysis, careful medication management, and vigilant monitoring of lab values, the patient's condition could stabilize, allowing for a more comprehensive approach to managing chronic kidney disease and preventing further systemic complications.
Section 4
As the healthcare team continued to manage the patient's condition, they remained vigilant for any changes that could signal new complications or necessitate adjustments in the treatment plan. On the morning of the fourth day, during routine rounds, the nurse noted that the patient reported mild shortness of breath and a feeling of increased fatigue despite the recent improvements in alertness. These symptoms prompted further investigation, and upon auscultation, mild crackles were heard at the lung bases, suggesting possible fluid overload. A chest X-ray was ordered, which confirmed mild pulmonary congestion, likely a result of fluid shifts from the recent dialysis sessions.
The team reviewed the patient's fluid balance, noting a positive fluid status over the past 24 hours. The nephrologist adjusted the dialysis prescription to include ultrafiltration to better manage fluid removal, while maintaining close monitoring of the patient's electrolyte levels and hemodynamic status. Given the elevated serum phosphorus level and the current signs of fluid overload, the decision was made to increase the dose of the phosphate binder and to reassess the patient's dietary intake to ensure adherence to fluid and phosphorus restrictions.
Despite these measures, the patient's blood pressure remained elevated at 160/95 mmHg, necessitating further consideration of the antihypertensive regimen. The healthcare team discussed the potential need for additional medication adjustments, including the possibility of introducing a diuretic to aid in both blood pressure control and fluid management. The team emphasized the importance of monitoring the patient's renal function and electrolytes closely, anticipating that these interventions would help stabilize the patient's condition and reduce the risk of further complications. As they awaited the next set of lab results, the team remained focused on refining the treatment plan to optimize the patient's clinical outcomes.
Section 5
As the healthcare team continued to monitor the patient closely, they observed a change in the patient's status later that afternoon. The patient began to exhibit increased anxiety and restlessness, which was accompanied by a noticeable increase in respiratory rate to 24 breaths per minute. The patient's oxygen saturation had decreased slightly to 92% on room air, prompting the nurse to administer supplemental oxygen via nasal cannula. Heart rate was noted to be 110 beats per minute, and blood pressure remained elevated at 165/100 mmHg. These changes raised concerns about the effectiveness of the current fluid management strategy and the potential for further complications.
The laboratory results from the morning returned, revealing a serum potassium level of 5.8 mEq/L, which was higher than previous levels and suggested a risk for hyperkalemia. Additionally, the patient's BUN and creatinine levels had increased, indicating a potential worsening of renal function. In response to these findings, the nephrologist adjusted the dialysis prescription once more, increasing the frequency and duration of sessions to address both electrolyte imbalances and fluid overload more effectively. The healthcare team also decided to initiate a low-dose loop diuretic, which would help manage both the elevated blood pressure and fluid retention, while being vigilant for signs of hypokalemia due to the diuretic therapy.
Recognizing the complexity of the patient's condition, the healthcare team held a multidisciplinary meeting to ensure a holistic approach to care. They emphasized the importance of continuous monitoring of the patient's vital signs, electrolytes, and renal function. Education was provided to the patient and family regarding the signs and symptoms of fluid overload and electrolyte imbalances to enhance early detection and timely intervention. The team remained committed to refining the treatment plan, anticipating that these strategic adjustments would stabilize the patient's condition and prevent further deterioration. As they awaited the next round of results and clinical assessments, the focus remained on maintaining a delicate balance between fluid removal and electrolyte management.